Live Breaking News & Updates on ஆண்ட்ரூ அறிவாற்ற்ல்

Stay updated with breaking news from ஆண்ட்ரூ அறிவாற்ற்ல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Biogen Alzheimer's drug hits roadblocks with some hospitals, insurers


5 Min Read
(Reuters) -Biogen Inc’s Alzheimer’s drug, the first new treatment for the memory-robbing disease in nearly 20 years, hit new barriers on Thursday with some large hospitals declining to use it and health insurers delaying a decision while awaiting coverage terms from Medicare.
FILE PHOTO: Aduhelm, Biogen s controversial recently approved drug for early Alzheimer s disease, is seen at Butler Hospital, one of the clinical research sites in Providence, Rhode Island, U.S. June 16, 2021. Jessica Rinaldi/Pool via REUTERS
An influential panel of medical experts also voted unanimously that there is no evidence that the drug, Aduhelm, provides a net health benefit to patients. ....

United States , North Carolina , Chris Leibman , Sam Gandy , Julie Steenhuysen , Deena Beasley , Howard Goller , Daniel Wallis , Yatin Suneja , Manas Mishra , Andrew Witty , Neurology Center , Biogen Inc Alzheimer , Thomson Reuters Trust Principles , Institute Of Clinical , Drug Administration , Unitedhealth Group , Centers For Medicare , York Mount Sinai Health System , Mount Sinai Center , Medicaid Services , Cognitive Health , Biogen Inc , Economic Review , Cleveland Clinic , New York ,